Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,826 | -12,210 | -9,168 | -4,667 | -2,411 |
| Depreciation Amortization | 37 | 1,022 | 1,014 | 709 | 425 |
| Accounts receivable | 106 | -64 | 34 | -85 | -106 |
| Other Working Capital | 961 | 615 | 1,715 | 981 | 251 |
| Other Operating Activity | 426 | 7,071 | 3,557 | 1,273 | 755 |
| Operating Cash Flow | $-296 | $-3,566 | $-2,847 | $-1,789 | $-1,087 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -32 | -13 | -8 | N/A |
| Investing Cash Flow | $N/A | $-32 | $-13 | $-8 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 467 | N/A | N/A | N/A |
| Debt Repayment | -10 | -772 | -678 | -466 | -328 |
| Common Stock Issued | 257 | 3,846 | 3,566 | 2,217 | 2,217 |
| Financing Cash Flow | $247 | $3,540 | $2,888 | $1,752 | $1,889 |
| Beginning Cash Position | 81 | 139 | 139 | 139 | 139 |
| End Cash Position | 32 | 81 | 166 | 95 | 942 |
| Net Cash Flow | $-49 | $-58 | $27 | $-45 | $803 |
| Free Cash Flow | |||||
| Operating Cash Flow | -296 | -3,566 | -2,847 | -1,789 | -1,087 |
| Capital Expenditure | N/A | -32 | -13 | -8 | N/A |
| Free Cash Flow | -296 | -3,598 | -2,861 | -1,797 | -1,087 |